US2012277258A1PendingUtilityA1

Chemical Compounds

57
Assignee: BOLOOR AMOGHPriority: Dec 21, 2000Filed: Jul 10, 2012Published: Nov 1, 2012
Est. expiryDec 21, 2020(expired)· nominal 20-yr term from priority
Inventors:Amogh BoloorMui CheungPhilip Anthony HarrisKevin HinkleChristopher Patrick LaudemanJeffrey Alan StaffordJames Marvin Veal
A61P 7/00A61P 35/00A61P 9/00A61P 27/02C07D 413/14C07D 235/08C07D 239/30A61P 27/10C07D 403/12C07D 231/56C07D 401/12
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.

Claims

exact text as granted — not AI-modified
1 - 10 . (canceled) 
     
     
         11 . A pharmaceutical composition comprising 1) a compound which is an inhibitor of erb-B2 and 2) a HCl salt of the compound

Join the waitlist — get patent alerts

Track US2012277258A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.